JAZZ | Jazz Pharmaceuticals plc | 轉虧為盈 | 16.9% |
CAI | Caris Life Sciences, Inc. | 轉虧為盈 | 轉虧為盈 |
ALNY | Alnylam Pharmaceuticals, Inc. | 轉虧為盈 | 轉虧為盈 |
PTCT | PTC Therapeutics, Inc. | 轉虧為盈 | 轉虧為盈 |
TECH | Bio-Techne Corporation | 轉虧為盈 | 13.6% |
RPRX | Royalty Pharma plc | 1323.2% | -47% |
SOLV | Solventum Corporation | 858.6% | 937.7% |
ARGX | argenx SE | 623.9% | 轉虧為盈 |
PODD | Insulet Corporation | 273.2% | 13% |
THC | Tenet Healthcare Corporation | 120.9% | -27.5% |
ALC | Alcon Inc. | 104.4% | -9.9% |
MCK | McKesson Corporation | 99.4% | 360.6% |
RDY | Dr. Reddy's Laboratories Limited | 98.9% | 14.5% |
CAH | Cardinal Health, Inc. | 95.3% | 8.2% |
DHR | Danaher Corporation | 88.3% | 11% |
RGEN | Repligen Corporation | 85% | 轉虧為盈 |
SNN | Smith & Nephew plc | 65.3% | 71.9% |
EXEL | Exelixis, Inc. | 65.2% | 64.1% |
HLN | Haleon plc | 60.7% | 11% |
AMGN | Amgen Inc. | 59.4% | 13.6% |
DXCM | DexCom, Inc. | 53.2% | 110.8% |
BDX | Becton, Dickinson and Company | 48.6% | 17.1% |
NVS | Novartis AG | 43.2% | 23.2% |
GILD | Gilead Sciences, Inc. | 39.7% | 143.6% |
HQY | HealthEquity, Inc. | 39.6% | 806.4% |
CI | Cigna Corporation | 36.2% | 152.8% |
UHS | Universal Health Services, Inc. | 34% | 44.2% |
LLY | Eli Lilly and Company | 31.4% | 475.3% |
ATR | AptarGroup, Inc. | 26.2% | 27.7% |
MRK | Merck & Co., Inc. | 25.5% | 83.2% |
FMS | Fresenius Medical Care AG & Co. KGaA | 25.1% | 29% |
MEDP | Medpace Holdings, Inc. | 20.2% | 15.3% |
HCA | HCA Healthcare, Inc. | 16% | 31.8% |
WST | West Pharmaceutical Services, Inc. | 14.9% | 2.9% |
NBIX | Neurocrine Biosciences, Inc. | 14.9% | 61.4% |
STE | STERIS plc | 14.4% | 27.9% |
CELG-RI | Bristol-Myers Squibb Company Ce | 13.7% | 81.8% |
BMY | Bristol-Myers Squibb Company | 13.6% | 81.8% |
VEEV | Veeva Systems Inc. | 12.4% | 27.1% |
QGEN | Qiagen N.V. | 10.7% | 32.6% |
PFE | Pfizer Inc. | 10.5% | -20.8% |
PEN | Penumbra, Inc. | 7% | 55.3% |
MDT | Medtronic plc | 6.2% | 8.2% |
A | Agilent Technologies, Inc. | 4.3% | 23.6% |
ELV | Elevance Health Inc. | 3.6% | 17% |
WAT | Waters Corporation | 3.3% | -7.8% |
COO | The Cooper Companies, Inc. | 3.3% | -28% |
IDXX | IDEXX Laboratories, Inc. | 3.2% | 17.9% |
ENSG | The Ensign Group, Inc. | 3.1% | 6.9% |
TMO | Thermo Fisher Scientific Inc. | 2.7% | -0.9% |
MTD | Mettler-Toledo International Inc. | 1.8% | 2.8% |
HSIC | Henry Schein, Inc. | 0.8% | 2% |
GRFS | Grifols, S.A. | 0.8% | 145.6% |
REGN | Regeneron Pharmaceuticals, Inc. | 0.1% | 8.9% |
ZTS | Zoetis Inc. | -2.1% | 5.7% |
DVA | DaVita Inc. | -3.1% | -30% |
ABT | Abbott Laboratories | -5% | -0.1% |
GEHC | GE HealthCare Technologies Inc. | -5.3% | -5.3% |
CRL | Charles River Laboratories International, Inc. | -6.3% | -20.8% |
UTHR | United Therapeutics Corporation | -7.1% | 9.6% |
ISRG | Intuitive Surgical, Inc. | -7.1% | 24.7% |
HOLX | Hologic, Inc. | -7.1% | 4.9% |
IQV | IQVIA Holdings Inc. | -7.6% | 16.1% |
RMD | ResMed Inc. | -7.6% | 11.9% |
JNJ | Johnson & Johnson | -8.1% | 91.2% |
INCY | Incyte Corporation | -8.3% | 298.4% |
LH | Labcorp Holdings Inc. | -9.1% | 54.2% |
DOCS | Doximity, Inc. | -9.6% | 40.6% |
BIIB | Biogen Inc. | -10.5% | 20.1% |
ZBH | Zimmer Biomet Holdings, Inc. | -11.5% | -7.3% |
EHC | Encompass Health Corporation | -12.5% | 16.9% |
AZN | AstraZeneca PLC | -16.2% | 77.3% |
DGX | Quest Diagnostics Incorporated | -18.3% | 8.4% |
RVTY | Revvity, Inc. | -19.3% | -50.4% |
SYK | Stryker Corporation | -21.3% | 3% |
VRTX | Vertex Pharmaceuticals Incorporated | -22% | 3.6% |
GSK | GSK plc | -22.3% | 轉虧為盈 |
NVO | Novo Nordisk A/S | -25.2% | -26.7% |
UNH | UnitedHealth Group Incorporated | -28% | -61.2% |
ONC | BeOne Medicines Ltd. | -33.8% | 轉虧為盈 |
BSX | Boston Scientific Corporation | -35.5% | 61% |
EW | Edwards Lifesciences Corporation | -36.8% | -90.5% |
GMED | Globus Medical, Inc. | -38.4% | 129.5% |
HALO | Halozyme Therapeutics, Inc. | -39.3% | 27.9% |
TEVA | Teva Pharmaceutical Industries Limited | -40.8% | 轉虧為盈 |
PHG | Koninklijke Philips N.V. | -48.3% | 1.7% |
ALGN | Align Technology, Inc. | -51.4% | -51.1% |
CORT | Corcept Therapeutics Incorporated | -52.7% | -58.5% |
SNY | Sanofi | -57.4% | -0.5% |
MOH | Molina Healthcare, Inc. | -64.2% | -75.8% |
ILMN | Illumina, Inc. | -65.1% | -78.7% |
HUM | Humana Inc. | -68.2% | -59.4% |
HIMS | Hims & Hers Health, Inc. | -74.6% | -79.1% |
GMAB | Genmab A/S | -81.4% | -68.3% |
ABBV | AbbVie Inc. | -88.1% | -88.1% |
ICLR | ICON Public Limited Company | -98.8% | -98.8% |
TAK | Takeda Pharmaceutical Company Limited | -100% | -100% |
BRKR | Bruker Corporation | -100% | -100% |
COR | Cencora, Inc. | -100% | -100% |
BMRN | BioMarin Pharmaceutical Inc. | -100% | -100% |
BIO | Bio-Rad Laboratories, Inc. | -100% | -100% |
IONS | Ionis Pharmaceuticals, Inc. | -100% | - |
ARWR | Arrowhead Pharmaceuticals, Inc. | -100% | - |
MASI | Masimo Corporation | -100% | -100% |
BAX | Baxter International Inc. | -100% | -100% |
ELAN | Elanco Animal Health Incorporated | -100% | -100% |
AVTR | Avantor, Inc. | -100% | -100% |
CVS | CVS Health Corporation | -100% | -100% |
ASND | Ascendis Pharma A/S | - | - |
AXSM | Axsome Therapeutics, Inc. | - | - |
TEM | Tempus AI, Inc. | - | - |
ABVX | Abivax S.A. | - | - |
GH | Guardant Health, Inc. | - | - |
EXAS | Exact Sciences Corporation | - | - |
SMMT | Summit Therapeutics Inc. | - | - |
VTRS | Viatris Inc. | - | -100% |
INSM | Insmed Incorporated | - | - |
BBIO | BridgeBio Pharma, Inc. | - | - |
NTRA | Natera, Inc. | - | - |
RYTM | Rhythm Pharmaceuticals, Inc. | - | - |
RVMD | Revolution Medicines, Inc. | - | - |
ROIV | Roivant Sciences Ltd. | - | - |
RNA | Avidity Biosciences, Inc. | - | - |
MDGL | Madrigal Pharmaceuticals, Inc. | - | - |
BNTX | BioNTech SE | - | -100% |
CNC | Centene Corporation | - | -100% |
MRNA | Moderna, Inc. | - | -100% |
MRUS | Merus N.V. | - | - |
CYTK | Cytokinetics, Incorporated | - | - |
NUVL | Nuvalent, Inc. | - | - |
MTSR | Metsera, Inc. | - | - |